Renal Denervation Market Share, Opportunities, Industry 2031

Report Description

The global renal denervation market size was valued at around USD 41.8 million in 2021 and is anticipated to expand at a CAGR of 43.4% during the forecast period, 2022–2030. The growth of the market is attributed to the rising cases of drug-resistant hypertension.

Get Free Sample Report

Renal denervation is a minimal invasive treatment to cure hypertension. Hypertension is a modifiable risk factor for cardiovascular devices disease and mortality. The renal denervation process uses ultrasound ablation or radiofrequency upon nerves in the renal artery to reduce the overactive signals and it lowers blood pressure. The kidneys, heart, and brain communicate through nerves to control blood pressure. Renal denervation is an innovative treatment that eliminates or reduces the need of high blood pressure medication. Renal denervation is a type of irregular heartbeat, which is caused by insufficient blood flow in the ventricles. Therefore, the blood may clot and get blocked in the arteria at the same time. These clots enter into the circulation and if it reaches the brain, it causes stroke. In renal denervation, heartbeat is out of sync, irregular, and it causes chest pain, weakness, fainting or shortness of breath. Renal denervation with radiofrequency is a catheter-based procedure that involves inserting a catheter into the renal artery via femoral artery. A one-time procedure is enough to lower blood pressure for two years.

The COVID-19 pandemic negatively affected the sales of renal denervation companies. Supply of renal denervation equipment was halted, due to the imposed lockdowns and lack of manpower. This disrupted the supply chain of many industries. However, reopening of manufacturing industries and introduction of vaccines to prevent coronavirus are projected to boost the renal denervation market.

Market Trends, Drivers, Restraints, and Opportunities

• Increasing level of daily alcohol consumption by people is expected to drive the market during the forecast period.
• Changing lifestyles and improvement in healthcare infrastructures in developing nations are anticipated to propel the market.
• Extensive approval process for renal denervation devices is projected to hamper the market in the coming years.
• Patient discomfort and anxiety during treatment is anticipated to hinder the market.
• Advancement in technology is expected to create lucrative opportunities for market players.

Scope of the Report

The report on the global renal denervation market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Market Segment Insights

Ultrasound segment to expand at a considerable CAGR

On the basis of technology, the renal denervation market is segregated into radiofrequency-based, ultrasound, pharmacologic, and micro-infusion. The radiofrequency-based segment is projected to expand at a considerable CAGR during the forecast period, owing to the safety, time efficiency, and its advantages. Ultrasound systems overcome the limitations of radiofrequency-based systems by reducing injuries to the renal arteries. Ultrasound systems produce high frequency sound waves and ablate the nerves without getting in direct contact with the tissues. Therefore, the ultrasound segment is anticipated to account for a major market share during the forecast period.

Get Free Sample Report

Vessix segment to expand at a significant CAGR

Based on products, the renal denervation market is divided into EnligHTN, symplicity, vessix (v2), Iberis, and others. The vessix segment is expected to hold a significant share of the market in the coming years, due to increasing demand for treatment of hypertension and other diseases. Vessix has a full-color visual user interface, which improves the accuracy and functionality of a device. Vessix system is suitable for arteries of different sizeds. The EnligHTN segment accounts for a significant market share, due to the rising burden of chronic diseases among adults and children.

Hospitals segment to expand at substantial CAGR

On the basis of end-users, the renal denervation market is segmented into ambulatory surgical centers, clinics, hospitals, and others. The hospitals segment is anticipated to expand at substantial CAGR during the forecast period, owing to the improved healthcare infrastructure and increasing number of invasive surgeries. The clinics segment is expected to hold a significant share of the market, due to rising number of clinical trials.

Europe is anticipated to constitute a key market share

In terms of regions, the renal denervation market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. Europe is expected to constitute a key share of the market during the forecast period, owing to increasing R&D activities for the development of efficient devices. The market in North America is anticipated to expand at a rapid pace during the forecast period, due to increased incidence of uncontrolled hypertension in the region.

Get Free Sample Report